Keagan Casey

Harvard University - Cambridge / United States

Others

AD Scientific Index ID: 5978507

Registration, Add Profile,
Premium Membership

Print Your Certificate

Keagan Casey's MOST POPULAR ARTICLES

1-) Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesR Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ...The Lancet 396 (10266), 1885-1894, 20202912020

2-) Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMJ Frigault, J Dietrich, K Gallagher, M Roschewski, JT Jordan, D Forst, ...Blood, The Journal of the American Society of Hematology 139 (15), 2306-2315, 2022902022

3-) UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a …R Benjamin, N Jain, MV Maus, N Boissel, C Graham, A Jozwik, D Yallop, ...The Lancet Haematology 9 (11), e833-e843, 2022612022

4-) Acute kidney injury after the CAR-T therapy tisagenlecleucelMD Lee, IA Strohbehn, HS Seethapathy, N Rusibamayila, KS Casey, ...American Journal of Kidney Diseases 77 (6), 990-992, 2021212021

5-) Phase 1 study of CD37-directed CAR T cells in patients with relapsed or refractory CD37+ hematologic malignanciesMJ Frigault, YB Chen, KME Gallagher, NK Horick, A El-Jawahri, I Scarfò, ...Blood 138, 653, 2021122021

ARTICLES

Add your articles